Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-05 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |